ESR1 and breast cancer: There is evidence that PARP1 regulates estrogen-dependent breast cancer cell growth through the modulation of the estrogen receptor (ER)-insulin-like growth factor 1 receptor (IGF-1R)-Na(+)/H(+) exchange regulatory cofactor NHE-RF3 (PDZK1) axis.